24 March 2022 - final results
The AIM-listed sleep wellness company has released final results for 2021, which were in line with a trading update released on 19 January. Group revenue increased by 5% to £26.6m (2020: £25.2m). On two-year pre-Covid comparatives, revenue was up 11% and there was a 40% reduction in marketing spend over the same period. Group EBITDA losses were £3.0m (2020: loss of £2.0m) reflecting additional investment in France. This was a 73% reduction on 2019 pre-Covid loss levels of £10.7m. The increased EBITDA loss meant that the . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
